These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1287 related articles for article (PubMed ID: 8033972)

  • 1. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.
    Ravindranath MH; Brazeau SM; Morton DL
    Experientia; 1994 Jul; 50(7):648-53. PubMed ID: 8033972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides.
    Ravindranath MH; Morton DL; Irie RF
    J Autoimmun; 1994 Dec; 7(6):803-16. PubMed ID: 7888037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.
    Ravindranath MH; Kelley MC; Jones RC; Amiri AA; Bauer PM; Morton DL
    Int J Cancer; 1998 Jan; 75(1):117-24. PubMed ID: 9426699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.
    Alonso DF; Gabri MR; Guthmann MD; Fainboim L; Gomez DE
    Int J Oncol; 1999 Jul; 15(1):59-66. PubMed ID: 10375594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.
    Gabri MR; Ripoll GV; Alonso DF; Gómez DE
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):669-77. PubMed ID: 12474053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.
    Carr A; Mazorra Z; Alonso DF; Mesa C; Valiente O; Gomez DE; Perez R; Fernandez LE
    Melanoma Res; 2001 Jun; 11(3):219-27. PubMed ID: 11468510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine.
    Johnston D; Bystryn JC
    J Natl Cancer Inst; 1991 Sep; 83(17):1240-5. PubMed ID: 1870150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
    Nores GA; Dohi T; Taniguchi M; Hakomori S
    J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge.
    Mazorra Z; Mesa C; Fernández A; Fernández LE
    Cancer Immunol Immunother; 2008 Dec; 57(12):1771-80. PubMed ID: 18351335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape mechanisms of melanoma from immune system by soluble melanoma antigen.
    Takahashi K; Ono K; Hirabayashi Y; Taniguchi M
    J Immunol; 1988 May; 140(9):3244-8. PubMed ID: 2452202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density of GM3 with normal primary structure determines mouse melanoma antigenicity; a new concept of tumor antigen.
    Harada Y; Sakatsume M; Nores GA; Hakomori S; Taniguchi M
    Jpn J Cancer Res; 1989 Oct; 80(10):988-92. PubMed ID: 2533193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GM3 ganglioside as melanoma specific antigen and its biological function].
    Hirabayashi Y; Taniguchi M
    Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.
    Yamamoto S; Yamamoto T; Saxton RE; Hoon DS; Irie RF
    J Natl Cancer Inst; 1990 Nov; 82(22):1757-60. PubMed ID: 1700134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
    Dohi T; Nores G; Hakomori S
    Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of melanoma antigen and its involvement in tumor-escape mechanisms.
    Taniguchi M; Sakatsume M; Harada Y; Nores GA; Hakomori S
    Princess Takamatsu Symp; 1988; 19():247-54. PubMed ID: 2978619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.
    Harada Y; Sakatsume M; Taniguchi M
    Jpn J Cancer Res; 1990 Apr; 81(4):383-7. PubMed ID: 2142151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of intracerebral tumour protection by active-specific immunization against murine melanoma B16/G3.12.
    Staib L; Harel W; Mitchell MS
    Melanoma Res; 2001 Aug; 11(4):325-35. PubMed ID: 11479420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the adjuvant MPL + TDM on tumor challenge in the B16 mouse melanoma model.
    Price JA; McGee JM; Patten MR; Snyder D
    Int J Immunopharmacol; 1996 Feb; 18(2):163-5. PubMed ID: 8799366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.